London & Capital Asset Management’s Merck MRK Stock Holding History

London & Capital Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.36M	Buy	11,289 +99	+0.9%	+$11.4K	0.01%	98
2025 Q4	$1.18M	Buy	+11,190	New	+$1.05M	0.01%	118
2020 Q3	–	Sell	-5,941	Closed	-$438K	–	92
2020 Q2	$438K	Buy	5,941 +1,886	+47%	+$142K	0.08%	69
2020 Q1	$298K	Hold	4,055	–	–	0.07%	65
2019 Q4	$352K	Sell	4,055 -891	-18%	-$73.2K	0.06%	74
2019 Q3	$397K	Buy	4,946 +1,967	+66%	+$158K	0.07%	68
2019 Q2	$238K	Sell	2,979 -1,631	-35%	-$125K	0.05%	80
2019 Q1	$366K	Sell	4,610 -44	-0.9%	-$3.29K	0.06%	64
2018 Q4	$339K	Buy	+4,654	New	+$329K	0.05%	70

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

London & Capital Asset Management's MRK Position: Q1 2026 in Review

London & Capital Asset Management increased its Merck (MRK) stake by 0.88% in Q1 2026, buying an estimated $11.4K and bringing the position to 11,289 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #98.

London & Capital Asset Management first reported a position in MRK in Q4 2018 and has held it in 9 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

London & Capital Asset Management held 11,289 shares of Merck worth $1.36M as of Q1 2026.
London & Capital Asset Management bought 99 Merck shares in Q1 2026, an estimated $11.4K.
Merck made up 0.01% of London & Capital Asset Management's portfolio in Q1 2026, its #98 holding.
London & Capital Asset Management first reported a position in Merck in Q4 2018 and has held it in 9 quarters since.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on London & Capital Asset Management's 13F filing for Q1 2026, filed 15 May 2026.